Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Mercado Continuo Espanol  >  Grifols SA       ES0171996012

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (€)
Sales 2016 4 154 M
EBIT 2016 1 046 M
Net income 2016 573 M
Debt 2016 3 455 M
Yield 2016 1,75%
Sales 2017 4 316 M
EBIT 2017 1 108 M
Net income 2017 660 M
Debt 2017 3 172 M
Yield 2017 1,93%
P/E ratio 2016 23,40
P/E ratio 2017 20,36
EV / Sales2016 3,75x
EV / Sales2017 3,55x
Capitalization 12 136 M
More Financials
Company
Grifols SA is a vertically integrated global producer of plasma derivatives.Its activities include sourcing raw material, manufacturing various plasma derivative products and selling and distributing final products to healthcare providers.The company operates through four segments: Bioessence,... 
Sector
Pharmaceuticals
Calendar
07/28Earnings Release
More about the company
Surperformance© ratings of Grifols SA
Trading Rating : Investor Rating :
More Ratings
Latest news on GRIFOLS SA
06/29 GRIFOLS : Award Winner of the 2016 SPIN Awards Program
06/21 GRIFOLS : FDA Approves Use of the Procleix Zika Virus Assay from Hologic and Gri..
06/16 GRIFOLS : confirms that it has voluntarily signed the EFPIA Code of Conduct
06/16 GRIFOLS : confirms that it has voluntarily signed the EFPIA Code of Conduct
06/14 JUNE 2016 TECH GUIDE : Immunoassay Analyzers
06/11 GRIFOLS : to Install the Kiro Oncology Robot at Smilow Cancer Hospital
06/02 GRIFOLS SA : ex-dividend day for annual dividend
05/27 GRIFOLS : allocates EUR 213 million to dividends and maintains pay-out at 40% of..
05/27 GRIFOLS : allocates EUR 213 million to dividends and maintains pay-out at 40% of..
05/19 ARADIGM : Announces First Quarter 2016 Financial Results
More news
Sector news : Biopharmaceuticals
01:59pDJGLAXOSMITHKLINE : Starts Phase-1 for Antibody Clinical Trial
08:51aDJMONSANTO : Shops Around For 'Right Combination' -- WSJ
03:32aDJSHANGHAI FOSUN PHARMACEUTICAL () : Approves Listing of 66.2%-Owned Sisram Medica..
06/29DJSHIRE : Correction to Story on Shire's ADHD Drug
06/29DJBAYER : EU Signals Strict Review of Bayer, Monsanto Deal -- 3rd Update
More sector news : Biopharmaceuticals
News from SeekingAlpha
01/04 Midday Gainers / Losers
2015 Tracking John Paulson's Paulson & Company Portfolio - Q3 2015 Update
2015 TiGenix Achieves First Ever Success In Allogeneic Stem Cell Phase 3 Trial
2015 Tracking John Paulson's Paulson & Company Portfolio - Q2 2015 Update
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Chart GRIFOLS SA
Duration : Period :
Grifols SA Technical Analysis Chart | ES0171996012 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions